FDA's REdI Conference 2026: Regulatory Strategies for Pharma
The FDA's REdI Annual Conference 2026 focuses on regulatory strategies for medical products, covering topics like advanced drug manufacturing and AI in drug development. The conference provides direct input from FDA experts on foundational regulatory requirements.
Key Takeaways
- The FDA's REdI Annual Conference 2026 will focus on regulatory strategies for medical products.
- Key presentations will cover advanced drug manufacturing, the use of AI in drug development, and the FDA's Quality Management System Regulation (QMSR).
- The conference offers direct insights from FDA experts on essential regulatory requirements.
The Regulatory Education for Industry (REdI) Annual Conference 2026, hosted by the FDA, will take place on May 19-20, 2026. The conference, titled "Innovative Regulatory Strategies to Advance Medical Products," is designed to provide attendees with crucial updates and insights into the FDA's regulatory framework for drugs, devices, and biologics.
This event is significant for pharmaceutical professionals seeking to stay informed about the latest regulatory changes and strategies. It offers a unique opportunity to hear directly from FDA experts and gain a deeper understanding of the agency's expectations for medical product development and approval.
Key Presentation Highlights
The REdI Annual Conference 2026 will feature several key presentations, including:
- Advanced Drug Manufacturing in CDER
- Use of AI to Advance Drug Development
- FDA’s Quality Management System Regulation (QMSR)
- Small Business Determination Program Updates
- Use of Digital Health Technologies for Data Collection in Clinical Trials
- Benefit-Risk Framework and Analytical Methods to Inform Benefit-Risk
Other Regulatory Events
In addition to the REdI Annual Conference, several other regulatory events are scheduled for 2026:
- Spring 2026 Regulatory Compliance Conference (Forvis Mazars/ProBank): April 20-23, 2026, in Lexington, KY, focusing on deposits, BSA, lending compliance, and leadership.
- Practice Compliance in 2026 Webinar (MGMA): April 22, 2026, covering HIPAA, Health IT/AI compliance, and enforcement trends.
- AACR Annual Meeting 2026: Dates TBD, focusing on regulatory science and policy in cancer research.
- FDLI Annual Conference: May 2026 (dates TBD), addressing legal and regulatory issues for FDA-regulated industries.
Frequently Asked Questions
-
What is the REdI Annual Conference?
The Regulatory Education for Industry (REdI) Annual Conference is an FDA-hosted event focused on regulatory strategies for medical products.
-
When and where will the REdI Annual Conference 2026 take place?
The conference will be held on May 19-20, 2026.
-
What are some of the key topics that will be covered at the conference?
Key topics include advanced drug manufacturing, AI in drug development, and the FDA's Quality Management System Regulation (QMSR).
